Synthesis and Biological Evaluation of Oleanolic Acid Derivative–chalcone Conjugates As Α-Glucosidase Inhibitors

Chu Tang,Linhui Zhu,Yu Chen,Rui Qin,ZhiNan Mei,Jing Xu,Guangzhong Yang

DOI: https://doi.org/10.1039/c3ra46492j

IF: 4.036

2014-01-01

RSC Advances

Abstract:Series of oleanolic acid derivative–chalcone conjugates were designed, synthesized and their α-glucosidase inhibitory activities were investigatedin vitro.

What problem does this paper attempt to address?

Synthesis and Evaluation of Coumarin-Chalcone Derivatives as α-Glucosidase Inhibitors

Chun-Mei Hu,Yong-Xin Luo,Wen-Jing Wang,Jian-Ping Li,Meng-Yue Li,Yu-Fei Zhang,Di Xiao,Li Lu,Zhuang Xiong,Na Feng,Chen Li

DOI: https://doi.org/10.3389/fchem.2022.926543

IF: 5.5

2022-06-27

Frontiers in Chemistry

Abstract:Coumarin and chalcone, two important kinds of natural product skeletons, both exhibit α-glucosidase inhibitory activity. In this work, coumarin-chalcone derivatives 3 ( a∼v ) were synthesized, and their α-glucosidase inhibitory activity was screened. The results showed that all synthetic derivatives (IC 50 : 24.09 ± 2.36 to 125.26 ± 1.18 μM) presented better α -glucosidase inhibitory activity than the parent compounds 3-acetylcoumarin (IC 50 : 1.5 × 10 5 μM) and the positive control acarbose (IC 50 : 259.90 ± 1.06 μM). Among them, compound 3t displayed the highest α -glucosidase inhibitory activity (IC 50 : 24.09 ± 2.36 μM), which was approximately 10 times stronger than that of acarbose. The kinetic assay of 3t ( K I = 18.82 μM, K IS = 59.99 μM) revealed that these compounds inhibited α-glucosidase in a mixed-type manner. Molecular docking was used to simulate the interaction between α-glucosidase and compound 3t .

chemistry, multidisciplinary
Design, synthesis and inhibition evaluation of novel chalcone amide α-glucosidase inhibitors

Song Yao Lv,Li Ping Cheng

DOI: https://doi.org/10.1080/17568919.2024.2347092

2024-07-02

Abstract:Aim: The purpose of this study is to design and synthesize a series of novel chalcone amide α-glucosidase (AG) inhibitors (L1-L10) based on virtual screening and molecular dynamics (MD) simulation. Materials & methods: Target compounds (L1-L10) were synthesized from 2-hydroxyacetophenone and methyl 4-formylbenzoate. Results: In vitro activity test shows that most compounds have good AG inhibition. Specially, compound L4 (IC50 = 8.28 ± 0.04 μM) had the best inhibitory activity, superior to positive control acarbose (IC50 = 8.36 ± 0.02 μM). Molecular docking results show that the good potency of L4 maybe attributed to strong interactions between chalcone skeleton and active site, and the torsion of carbon nitrogen bond in amide group. Conclusion: Compound L4 maybe regard as a good anti-Type II diabetes candidate to preform further study.
Discovery of Chalcone Derivatives As Bifunctional Molecules with Anti-SARS-CoV-2 and Anti-inflammatory Activities

Xuwen Chen,Hongtao Li,Meiting Wang,Donghui Sun,Jiani Lu,Tong Zhu,Hongzhuan Chen,Lili Chen,Shunying Liu

DOI: https://doi.org/10.1021/acs.jnatprod.4c00657

IF: 5.1

2024-01-01

Journal of Natural Products

Abstract:Danshensu extracted with traditional Chinese medicine Salvia miltiorrhiza has a wide range of bioactivities. Danshensu containing a catechol moiety has a moderate inhibitory effect on SARS-CoV-2 3CLpro (IC50 = 2.2 mu M) by a reversible covalent interaction and exhibits good anti-inflammatory activity. To enhance the inhibitory activity, we introduced Michael receptors into the side chain of danshensu as a possible covalent warhead and blocked the covalent binding sites of catechol moiety to yield chalcone derivatives. The resulting chalcone derivatives, A4 and A7, were found to inhibit SARS-CoV-2 3CLpro in vitro with IC50 values of 83.2 and 261.3 nM, respectively. Furthermore, A4 and A7 inhibit viral replication in the SARS-CoV-2 replicon system with EC50 values of 19.9 and 11.7 mu M, respectively. Time-dependent inhibition experiment and mass spectrometry show that A4 acted as a noncovalent mixed inhibitor, while A7 likely binds covalently at Cys145. The interaction mechanism between SARS-CoV-2 3CLpro and A4 or A7 was characterized by molecular docking studies. Additionally, both A4 and A7 demonstrated potent anti-inflammatory activity in lipopolysaccharide (LPS)-stimulated RAW264.7 macrophage cells. These promising results suggest that chalcone derivatives A4 and A7 can serve as bifunctional molecules with both antivirus and anti-inflammatory properties.
Chalcone derivatives as xanthine oxidase inhibitors: synthesis, binding mode investigation, biological evaluation, and ADMET prediction

Can Yang,Yi Liu,Yanbei Tu,Lizi Li,Jiana Du,Dehong Yu,Pei He,Tao Wang,Yan Liu,Hao Chen,Yanfang Li

DOI: https://doi.org/10.1016/j.bioorg.2022.106320

IF: 5.307

2023-02-01

Bioorganic Chemistry

Abstract:Xanthine oxidase (XO) is a crucial target for the treatment of hyperuricemia and gout. A series of derivatives based on natural 3,4-dihydroxychalcone, obtained from Carthamus tinctorious and Licorice, were designed and synthesized. Nine derivatives (9a-e, 10b,c, and 15a,b) exhibited apparent XO inhibitory activity in vitro (IC50 values varied from 0.121 to 7.086 μM), 15b presented the most potent inhibitory activity (IC50 = 0.121 µM), which was 27.47-fold higher than that of allopurinol (IC50 = 3.324 µM). The SAR analysis indicated that introducing hydroxyl groups at 3'/4'/5'-position on ring A was more beneficial to the inhibition of XO than at 2'/6'-position; the removal of 3‑hydroxyl group on ring B could weaken the inhibitory potency of hydroxychalcones on XO, but it was beneficial to the XO inhibitory potency of methoxychalcones. Molecule modeling studies afforded insights into the binding mode of 15b with XO and supported the findings of SAR analysis. Additionally, kinetics studies demonstrated that 15b presented a reversible and competitive XO inhibitor, which spontaneously combined with XO through hydrophobic force, and finally changed the secondary conformation of XO. Furthermore, the acute hyperuricemia model was employed to investigate the hypouricemic effect of 15b, which could effectively reduce the serum uric acid levels of rats at an oral dose of 10 mg/kg. ADMET prediction suggested that compound 15b possessed good pharmacokinetic properties. Briefly, compound 15b emerges as an interesting XO inhibitor for the treatment of hyperuricemia and gout with beneficial effects on serum uric acid levels regulating. Meanwhile, the XO inhibitors with chalcone skeleton will deserve further attention and discussion.

biochemistry & molecular biology,chemistry, organic
Synthesis and biological evaluation of novel ursolic acid analogues as potential α-glucosidase inhibitors

Pan-Pan Wu,Bing-Jie Zhang,Xi-Ping Cui,Yang Yang,Zheng-Yun Jiang,Zhi-Hong Zhou,Ying-Ying Zhong,Yu-Ying Mai,Zhong Ouyang,Hui-Sheng Chen,Jie Zheng,Su-Qing Zhao,Kun Zhang

DOI: https://doi.org/10.1038/srep45578

IF: 4.6

2017-03-30

Scientific Reports

Abstract:Ursolic acid (UA) is a major pentacyclic triterpenoid in plants, vegetables and fruits, which has been reported to have a potential anti-diabetic activity. Despite various semi-synthetic ursolic acid derivatives already described, new derivatives still need to be designed and synthesized to further improve the anti-diabetic activity. In the present study, two series of novel UA derivatives, were synthesized and their structures were confirmed. The enzyme inhibition activities of semi-synthesized analogues against α-glucosidase were screened in vitro. The results indicated that most of UA derivatives showed a significant inhibitory activity, especially analogues UA-O-i with the IC50 values of 0.71 ± 0.27 μM, which was more potential than other analogues and the positive control. Furthermore, molecular docking studies were also investigated to verify the in vitro study. Structure modification at the C-3 and C-2 positions of UA was an effective approach to obtain the desired ligand from UA, whose structure was in accordance with the active pocket. Besides, suitable hydrophobic group at the position of C-2 might play an important role for the docking selectivity and binding affinity between the ligand and the homology modelling protein. These results could be helpful for designing more potential α-glucosidase inhibitors from UA in the future.

multidisciplinary sciences
[Synthesis, Biological Activity and Molecular Docking Research of N-{[(4-oxo-thiochroman-3-yl)phenyl]-methyl}acetamide Derivatives As Α-Glucosidase Inhibitors].

Guan Zhou,Guo-chao Liang,Xiao-yan Han,Yi-fan Zhong,Yun-fang Dong,Xiao-cong Luo,Hong-wei Jin,Ya-li Song

DOI: https://doi.org/10.16438/j.0513-4870.2015-0687

2016-01-01

Abstract:In order to develop potent antidiabetic agents that have inhibitory effect to a-glucosidase, twelve β-acetamido ketone derivatives such as N-{[(substituted-4-oxo-thiochroman-3-yl)phenyl]-methyl}acetamide are designed and synthesized through one-pot Dakin-West reaction. Their chemical structures are confirmed by 1H NMR, 13C NMR, IR and HR-MS. In vitro α-glucosidase inhibition assays of compounds 4a-41 were carried out using glucose oxidase method. The result indicated that most of them possess inhibitory activity in vitro. Compound 4k showed the most potent inhibitory activity with 87.3% inhibition of α-glucosidase at the concentration of 5.39 mmol x L(-1). The structure-activity relationship of these β-acetamido ketone derivatives was discussed preliminarily. Moreover, the molecular docking method was used to study the interaction mode of compound 4k and α-glucosidase. Our results will be helpful for designing of α-glucosidase inhibitors in the future.
Development of coronary risk factors in young Oslo males. A comparison between a survey in 40 year old men and the Oslo Study in 1972/73.

I. Holme,S. Mogensen,I. Hjermann,P. Leren

1987-05-01

Abstract:
Design, synthesis, biological evaluation, and docking study of chromone-based phenylhydrazone and benzoylhydrazone derivatives as antidiabetic agents targeting α‐glucosidase

Meiyan Fan,Wei Yang,Lin Liu,Zhiyun Peng,Yan He,Guangcheng Wang

DOI: https://doi.org/10.1016/j.bioorg.2023.106384

IF: 5.307

2023-03-01

Bioorganic Chemistry

Abstract:To develop novel α-glucosidase inhibitors, a series of chromone-based phenylhydrazone and benzoylhydrazone derivatives were designed, synthesized, and evaluated their inhibitory effects on α-glucosidase. The target compounds were characterized using 1H NMR, 13C NMR, and high-resolution mass spectra. Some of the compounds showed a varying degree of α-glucosidase inhibitory activity with IC50 values ranging from 6.59 ± 0.09 to 158.55 ± 0.87 μM. Among them, compound 5c (IC50 = 6.59 ± 0.09 μM) was the most potent inhibitor by comparison with positive control acarbose (IC50 = 685.11 ± 7.46 μM). Enzyme kinetic, fluorescence analysis, circular dichroism spectra, and molecular docking techniques were employed to explain the underlying molecular mechanisms of 5c inhibition on α-glucosidase. In vivo sucrose-loading test showed that 5c could suppress the rise of blood glucose levels after loading sucrose in normal Kunming mice. The cytotoxicity assay indicated that 5c exhibited low cytotoxicity.

biochemistry & molecular biology,chemistry, organic
Synthesis and biological evaluation of the novel antitumor agent 3'-monosubstituted chalcone derivatives

luyao wang,hongye zhao,dan wu,long qin,yuou teng,kui lu

DOI: https://doi.org/10.2991/ic3me-15.2015.101

2015-01-01

Abstract:Seven novel 3'-mono-substituted chalcone derivatives were synthesized from 2,4-dihydroxyacetophenone in 4 steps in 18-31% overall yield. Their structures were confirmed by H-1 NMR. The anticancer activity of these new target compounds (4 similar to 10) against human leukemia K562 cells were evaluated by MTT assay in vitro. This study leads to the identification of one highly active molecule, compounds 10 (IC50 = 5.60 mu M) against K562.
Synthesis and Evaluation of Chalcone Derivatives as Prospective Anti-Inflammatory Compounds

Xueqian Bai,Zhe Liu,Yue Sheng,Fuyun Liu,Tianyi Zhang

DOI: https://doi.org/10.1007/s10600-024-04341-3

2024-05-22

Chemistry of Natural Compounds

Abstract:In order to discover novel anti-inflammatory agents, a series of compounds obtained by appending chalcone moieties on dehydroepiandrosterone were designed and synthesized. All compounds were screened for their anti-inflammatory activity by using an ear edema model. Most of the synthesized compounds showed potent anti-inflammatory activity at 100 mg/kg with inhibition rates ranging from 27.94% to 56.83%. It is noteworthy that compound 4e exhibited the most pronounced anti-inflammatory activity of all the compounds with an activity of 56.83%, which was higher than that of celecoxib (47.14%).

chemistry, medicinal, organic
Synthesis and anti-α-glucosidase activity evaluation of betulinic acid derivatives

Xiao-Zheng Wu,Wen-Jian Zhu,Li Lu,Chun-Mei Hu,Ying-Ying Zheng,Xin Zhang,Jing Lin,Jing-Ying Wu,Zhuang Xiong,Kun Zhang,Xue-Tao Xu

DOI: https://doi.org/10.1016/j.arabjc.2023.104659

IF: 6.212

2023-02-13

Arabian Journal of Chemistry

Abstract:In this article, a series of betulinic acid derivatives ( 3a ∼ 3u , 4a ∼ 4e ) were synthesized through a stepwise structure optimization and evaluated for their anti-α-glucosidase activities. All synthesized derivatives exhibited stronger anti-α-glucosidase activities (IC 50 : 0.56 ± 0.05 ∼ 3.99 ± 0.23 μM) than betulinic acid (IC 50 : 7.21 ± 0.58 μM) and acarbose (IC 50 : 611.45 ± 15.51 μM). Compound 3q presented the outstanding inhibitory activity (IC 50 : 0.56 ± 0.05 μM), which was ∼1100 time stronger than that of acarbose. Compound 3q was revealed as a reversible and noncompetitive α-glucosidase inhibitor by inhibitory mechanism assay. Fluorescence spectra, 3D fluorescence and CD spectra results showed that the interaction of compound 3q with α-glucosidase caused the conformational and secondary structure content change of α-glucosidase. Finally, the molecular docking simulated the interaction between compound 3q with α-glucosidase and the physicochemical parameter was assessed using SwissADME software.

chemistry, multidisciplinary
A novel strategy for stent deployment in the treatment of acute or threatened closure complicating balloon coronary angioplasty. Use of short or standard (or both) single or multiple Palmaz-Schatz stents.

A. Colombo,Steven L. Goldberg,Y. Almagor,L. Maiello,L. Finci

DOI: https://doi.org/10.1016/0735-1097(93)90774-U

IF: 24

1993-12-01

Journal of the American College of Cardiology

Abstract:
Synthesis, Molecular Modeling and Biological Evaluation of Chalcone Thiosemicarbazide Derivatives As Novel Anticancer Agents.

Hong-Jia Zhang,Yong Qian,Di-Di Zhu,Xu-Guang Yang,Hai-Liang Zhu

DOI: https://doi.org/10.1016/j.ejmech.2011.07.016

IF: 7.088

2011-01-01

European Journal of Medicinal Chemistry

Abstract:A series of novel chalcone thiosemicarbazide derivatives (4a-4x) have been designed, synthesized, structurally determined, and their biological activities were also evaluated as potential EGFR kinase inhibitors. All the synthesized compounds are first reported. Among the compounds, compound 4r showed the most potent biological activity (IC50 = 0.78 +/- 0.05 mu M for HepG2 and IC50 = 0.35 mu M for EGFR), which is comparable to the positive controls. Docking simulation was also performed to position compound 4r into the EGER active site to determine the probable binding model. Antiproliferative assay results demonstrated that some of these compounds possessed good antiproliferative activity against HepG2. Compound 4r with potent inhibitory activity in tumor growth inhibition may be a potential anticancer agent. Crown Copyright (C) 2011 Published by Elsevier Masson SAS. All rights reserved.
Synthesis, biological evaluation and action mechanism of 7H-[1,2,4] triazolo [3,4-b] [1,3,4] thiadiazine-phenylhydrazone derivatives as α-glucosidase inhibitors

Qianqian Feng,Jinfeng Zhang,Shuang Luo,Yong Huang,Zhiyun Peng,Guangcheng Wang

DOI: https://doi.org/10.1016/j.ejmech.2023.115920

2023-12-15

Abstract:In our work, several 7H-[1,2,4]triazolo[3,4-b][1,3,4]thiadiazine-phenylhydrazone derivatives as α-glucosidase inhibitors (α-GIs) were synthesized and characterized by 1H NMR, 13C NMR, and HRMS spectrum. Then, their bio-activity against the α-glucosidase (α-Glu) was further evaluated. Among them, almost all compounds displayed better bio-activity with IC50 from 31.23 ± 0.89 to 213.50 ± 4.19 μM than acarbose (IC50 = 700.20 ± 10.55 μM). In particular, compound 5o showed the best potency to inhibit α-Glu in a mixed manner. Moreover, the action mechanisms of 5o were further clarified including fluorescence quenching, circular dichroism spectra, three-dimensional fluorescence spectra, molecular docking, etc. All mechanism studies revealed that 5o could arouse the changed secondary structure of α-Glu to hinder enzyme catalytic activity. It was observed from an in vivo study that 5o of 20 mg/kg could significantly decrease by 24.45 % postprandial blood glucose in mice vs. the control. Meanwhile, 5o had low drug-drug interaction potential and was likely to be an orally active compound. Moreover, 5o was observed to be no obvious cytotoxicity to HEK-293 cells. In summary, compound 5o exhibited one potential to be further applied as an antidiabetic drug.
Chemical synthesis, inhibitory activity and molecular mechanism of 1-deoxynojirimycin–chrysin as a potent α-glucosidase inhibitor

Ran Zhang,Yueyue Zhang,Gaiqun Huang,Xiangdong Xin,Liumei Tang,Hao Li,Kwang Sik Lee,Byung Rae Jin,Zhongzheng Gui

DOI: https://doi.org/10.1039/d1ra07753h

IF: 4.036

2021-01-01

RSC Advances

Abstract:Hyperglycemia can be efficaciously regulated by inhibiting α-glucosidase activity and this is regarded as an effective strategy to treat type 2 diabetes.

chemistry, multidisciplinary
Synthesis and Biological Evaluation of Amino Chalcone Derivatives as Antiproliferative Agents

Chao-Fan Lu,Sheng-Hui Wang,Xiao-Jing Pang,Ting Zhu,Hong-Li Li,Qing-Rong Li,Qian-Yu Li,Yu-Fan Gu,Zhao-Yang Mu,Min-Jie Jin,Yin-Ru Li,Yang-Yang Hu,Yan-Bing Zhang,Jian Song,Sai-Yang Zhang

DOI: https://doi.org/10.3390/molecules25235530

IF: 4.6

2020-11-25

Molecules

Abstract:Chalcone is a common scaffold found in many biologically active compounds. The chalcone scaffold was also frequently utilized to design novel anticancer agents with potent biological efficacy. Aiming to continue the research of effective chalcone derivatives to treat cancers with potent anticancer activity, fourteen amino chalcone derivatives were designed and synthesized. The antiproliferative activity of amino chalcone derivatives was studied in vitro and 5-Fu as a control group. Some of the compounds showed moderate to good activity against three human cancer cells (MGC-803, HCT-116 and MCF-7 cells) and compound 13e displayed the best antiproliferative activity against MGC-803 cells, HCT-116 cells and MCF-7 cells with IC50 values of 1.52 μM (MGC-803), 1.83 μM (HCT-116) and 2.54 μM (MCF-7), respectively which was more potent than the positive control (5-Fu). Further mechanism studies were explored. The results of cell colony formatting assay suggested compound 10e inhibited the colony formation of MGC-803 cells. DAPI fluorescent staining and flow cytometry assay showed compound 13e induced MGC-803 cells apoptosis. Western blotting experiment indicated compound 13e induced cell apoptosis via the extrinsic/intrinsic apoptosis pathway in MGC-803 cells. Therefore, compound 13e might be a valuable lead compound as antiproliferative agents and amino chalcone derivatives worth further effort to improve amino chalcone derivatives’ potency.

chemistry, multidisciplinary,biochemistry & molecular biology
Design, synthesis and biological evaluation of novel chalcone-like compounds as potent and reversible pancreatic lipase inhibitors

Peng-Chao Huo,Qing Hu,Sheng Shu,Qi-Hang Zhou,Rong-Jing He,Jie Hou,Xiao-Qing Guan,Dong-Zhu Tu,Xu-Dong Hou,Peng Liu,Nan Zhang,Zhi-Guo Liu,Guang-Bo Ge

DOI: https://doi.org/10.1016/j.bmc.2020.115853

2021-01-01

Abstract:Pancreatic lipase (PL), a crucial enzyme responsible for hydrolysis of dietary lipids, has been validated as a key therapeutic target to prevent and treat obesity-associated metabolic disorders. Herein, we report the design, synthesis and biological evaluation of a series of chalcone-like compounds as potent and reversible PL inhibitors. Following two rounds of structural modifications at both A and B rings of a chalcone-like skeleton, structure-PL inhibition relationships of the chalcone-like compounds were studied, while the key substituents that would be beneficial for PL inhibition were revealed. Among all tested chalcone-like compounds, compound B13 (a novel chalcone-like compound bearing two long carbon chains) displayed the most potent PL inhibition activity, with an IC50 value of 0.33 μM. Inhibition kinetic analyses demonstrated that B13 could potently inhibit PL-mediated 4-MUO hydrolysis in a mixed inhibition manner, with the Ki value of 0.12 μM. Molecular docking simulations suggested that B13 could tightly bind on PL at both the catalytic site and a non-catalytic site that was located on the surface of PL, which was consistent with the mixed inhibition mode of this agent. In addition, B13 displayed excellent stability in artificial gastrointestinal fluids and good metabolic stability in human liver preparations. Collectively, our findings suggested that chalcone-like compounds were good choices for design and development of orally administrated PL inhibitors, while B13 could be served as a promising lead compound to develop novel anti-obesity agents via targeting on PL.

biochemistry & molecular biology,chemistry, medicinal, organic
Design, synthesis and evaluation of L-quebrachitol derivatives against α-glycosidase

Maoying Zhang,Xinjie Liang,Pengchen Cai,Qi-Xun Feng,Chen Yongsong,Yu Xiaoxi,Kuo Zhang,Xuefei Bao,Guoliang Chen

DOI: https://doi.org/10.1039/d3nj00889d

IF: 3.3

2023-06-14

New Journal of Chemistry

Abstract:Two series of L-quebrachitol derivatives have been designed and synthesized in order to search for novel hypoglycemic agents. The α-glycosidase inhibitory activities of these compounds were evaluated, and their structure-activity relationships (SARs) were discussed. Using Acarbose as the positive control, the activities of 16 synthesized compounds against α-glycosidase were evaluated with 4-nitrophenyl-α-D-glucopyranoside as substrate. The results showed that 16 compounds had significant inhibitory activities against α-glycosidase and 8 compounds (6b, 3b, 3c, 3e, 3h, 3i, 3j, 3l) out of them had stronger inhibitory activities than Acarbose. Among them, 3i has the strongest activity, which is 20 times stronger than that of Acarbose.

chemistry, multidisciplinary
Design, Synthesis and Biological Evaluation of Novel (E)-2-benzylidene-n-(3-cyano-4,5,6,7-tetrahydrobenzo[b]thiophen-2-yl)hydrazine-1-carboxamide Derivatives As Α-Glucosidase Inhibitors.

Jin-He Zhang,Hong-Xu Xie,Yue Li,Kai-Ming Wang,Zhiling Song,Kong-Kai Zhu,Lei Fang,Juan Zhang,Cheng-Shi Jiang

DOI: https://doi.org/10.1016/j.bmcl.2021.128413

IF: 2.94

2021-01-01

Bioorganic & Medicinal Chemistry Letters

Abstract:In this present study, a series of novel (E)-2-benzylidene-N-(3-cyano-4,5,6,7-tetrahydrobenzo[b]thiophen-2-yl)hydrazine-1-carboxamide derivatives against α-glucosidase were designed and synthesized, and their biological activities were evaluated in vitro and in vivo. Most of the designed analogues exhibited better inhibitory activity than the marketed acarbose, especially the most potent compound 7 with an IC50 value of 9.26 ± 1.84 μM. The direct binding of 7 and 8 with α-glucosidase was confirmed by fluorescence quenching experiments, and the kinetic and molecular docking studies revealed that 7 and 8 inhibited α-glucosidase in a non-competitive manner. Cytotoxicity bioassay indicated compounds 7 and 8 were non-toxic towards LO2 and HepG2 at 100 μM. Furthermore, both compounds were demonstrated to have in vivo hypoglycemic activity by reducing the blood glucose levels in sucrose-treated rats.
Synthesis and biological evaluation of coumarin derivatives containing oxime ester as α-glucosidase inhibitors

Xin Zhang,Ying-Ying Zheng,Chun-Mei Hu,Xiao-Zheng Wu,Jing Lin,Zhuang Xiong,Kun Zhang,Xue-Tao Xu

DOI: https://doi.org/10.1016/j.arabjc.2022.104072

IF: 6.212

2022-09-01

Arabian Journal of Chemistry

Abstract:In this study, potent coumarin derivatives containing oxime ester 1 ∼ 28 as α-glucosidase inhibitors were developed through a stepwise structure optimization, and the structure activity relationship was uncovered. Among them, compound 20 exhibited outstanding α-glucosidase inhibitory activity with IC50 of 2.54 ± 0.04 μM compared to 640.57 ± 1.13 μM of Acarbose. Kinetic study ascertained that compound 20 was a reversible and uncompetitive α-glucosidase inhibitor. 3D fluorescence results showed that the interaction of compound 20 with α-glucosidase caused the changes of microenvironments and polypeptide backbone structure of α-glucosidase. CD spectra results revealed that compound 20 decreased the α-helix content and increased the β-sheet content. Molecular docking analysis indicated that compound 20 well located into the active site and mainly bind with Phe157, His239, His279, Tyr71, and Arg312 to reduce the catalytic activity of α-glucosidase.

chemistry, multidisciplinary

Synthesis and Biological Evaluation of Oleanolic Acid Derivative–chalcone Conjugates As Α-Glucosidase Inhibitors

Synthesis and Evaluation of Coumarin-Chalcone Derivatives as α-Glucosidase Inhibitors

Design, synthesis and inhibition evaluation of novel chalcone amide α-glucosidase inhibitors

Discovery of Chalcone Derivatives As Bifunctional Molecules with Anti-SARS-CoV-2 and Anti-inflammatory Activities

Chalcone derivatives as xanthine oxidase inhibitors: synthesis, binding mode investigation, biological evaluation, and ADMET prediction

Synthesis and biological evaluation of novel ursolic acid analogues as potential α-glucosidase inhibitors

[Synthesis, Biological Activity and Molecular Docking Research of N-{[(4-oxo-thiochroman-3-yl)phenyl]-methyl}acetamide Derivatives As Α-Glucosidase Inhibitors].

Development of coronary risk factors in young Oslo males. A comparison between a survey in 40 year old men and the Oslo Study in 1972/73.

Design, synthesis, biological evaluation, and docking study of chromone-based phenylhydrazone and benzoylhydrazone derivatives as antidiabetic agents targeting α‐glucosidase

Synthesis and biological evaluation of the novel antitumor agent 3'-monosubstituted chalcone derivatives

Synthesis and Evaluation of Chalcone Derivatives as Prospective Anti-Inflammatory Compounds

Synthesis and anti-α-glucosidase activity evaluation of betulinic acid derivatives

A novel strategy for stent deployment in the treatment of acute or threatened closure complicating balloon coronary angioplasty. Use of short or standard (or both) single or multiple Palmaz-Schatz stents.

Synthesis, Molecular Modeling and Biological Evaluation of Chalcone Thiosemicarbazide Derivatives As Novel Anticancer Agents.

Synthesis, biological evaluation and action mechanism of 7H-[1,2,4] triazolo [3,4-b] [1,3,4] thiadiazine-phenylhydrazone derivatives as α-glucosidase inhibitors

Chemical synthesis, inhibitory activity and molecular mechanism of 1-deoxynojirimycin–chrysin as a potent α-glucosidase inhibitor

Synthesis and Biological Evaluation of Amino Chalcone Derivatives as Antiproliferative Agents

Design, synthesis and biological evaluation of novel chalcone-like compounds as potent and reversible pancreatic lipase inhibitors

Design, synthesis and evaluation of L-quebrachitol derivatives against α-glycosidase

Design, Synthesis and Biological Evaluation of Novel (E)-2-benzylidene-n-(3-cyano-4,5,6,7-tetrahydrobenzo[b]thiophen-2-yl)hydrazine-1-carboxamide Derivatives As Α-Glucosidase Inhibitors.

Synthesis and biological evaluation of coumarin derivatives containing oxime ester as α-glucosidase inhibitors